ArticlePediatric cardiology2026
Frequency and Progression of Lung Disease Patterns in Patients with Fontan and Tetralogy of Fallot.
Article in Pediatric cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Abnormal spirometry is common in patients with complex congenital heart disease (CHD) and is associated with impaired exercise capacity. This study evaluated longitudinal changes in spirometry and exercise capacity in tetralogy of Fallot (TOF) and Fontan patients through a retrospective chart review of spirometry and cardiopulmonary exercise tests (CPETs). All patients had a CPET with a respiratory exchange ratio (RER) greater than or equal to 1.00. The baseline CPET for patients with a single test was compared to patients with serial testing to evaluate for demographic or clinical differences. For serial testers, the first and last available CPETs were analyzed longitudinally. The study included 207 TOF patients and 147 patients with Fontan physiology. Eighty-seven TOF and 98 patients with Fontan physiology had serial testing over a mean follow-up of 5.5 ± 3.4 and 5.5 ± 3.9 years, respectively. Roughly half of the patients had abnormal spirometry for both TOF and Fontan cohorts, with restrictive lung disease patterns being the most prevalent. Several spirometry markers declined during serial testing; however, the magnitude of the decline was clinically insignificant. Spirometry measures of pulmonary function and markers of exercise capacity appear largely stable during an average 5 year follow up in our cohort of mostly adolescent and young adult TOF and Fontan patients.
Indexed as
Identifiers
42766121What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.